当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

抽象的な

Clinical Applications of Sentinel Lymph Node Biopsy: From Melanoma to Breast Cancer

Kinam Zhiang

Sentinel lymph node biopsy (SLNB) has evolved as a crucial technique in surgical oncology, revolutionizing cancer staging and therapeutic decision-making across various malignancies. This comprehensive review explores the clinical applications of SLNB, spanning the spectrum from melanoma to breast cancer. By focusing on these distinct tumor types, we aim to highlight the versatility and impact of SLNB in diverse clinical scenarios. In melanoma, SLNB has emerged as a gold standard for nodal staging, allowing for precise identification of sentinel lymph nodes and facilitating early detection of metastatic disease. We discuss the evolving role of SLNB in melanoma management, addressing its diagnostic accuracy, prognostic significance, and influence on treatment strategies. Breast cancer represents another area where SLNB has made significant inroads. Its utilization has enabled clinicians to tailor surgical approaches and adjuvant therapies, minimizing unnecessary axillary dissections and their associated morbidity. We examine the current guidelines and controversies surrounding SLNB in breast cancer, shedding light on its integration into multidisciplinary care.

免責事項: この要約は人工知能ツールを使用して翻訳されており、まだレビューまたは確認されていません。